# US 6,726,927 B2 · Preparation of enteric pharmaceutical dosage forms for omerprazole and lansoprazole

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,927 B2
- Document ID: US6726927B2
- Status: Granted
- Kind: B2
- Application number: 09/141,476
- Filed: 1998-08-27
- Published: 2001-07-05
- Granted: 2004-04-27
- Earliest claimed: 1997-05-09
- Assignees: Sage Pharmaceuticals, Inc.
- Inventors: Jivn-Ren Chen
- Web page: https://patentgrep.com/patent/US6726927B2

## CPC

- A61K 9/485: {Inorganic compounds}
- A61K 9/2886: {having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer (of the type active core-drug layer-inactive layer A61K9/209)}
- A61K 9/4866: {Organic macromolecular compounds}
- A61K 9/4891: {Coated capsules; Multilayered drug free capsule shells (with drug coating for immediate release A61K9/4808; osmotic devices A61K9/0004)}
- A61K 31/4184: condensed with carbocyclic rings, e.g. benzimidazoles
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61K 9/4808: {characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release (capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such a dosage forms, and to a method of gastric acid pump inhibition and providing gastrointestinal cytoprotective benefit by using them.

## Claims

### Claim 1

A process for manufacturing an oral pharmaceutical preparation of a core formulation comprising an acid-unstable drug and an alkaline substance, wherein the acid-unstable drug is omeprazole, sodium omeprazole, potassium omeprazole, lansoprazole, or a pharmaceutical salt of lansoprazole, the process consisting essentially of:
(a) preparing the core formulation by dry mixing, without using an aqueous granulating solution, the acid-unstable drug with the alkaline substance;
(b) quantitatively filling the core formulation into the hard gelatine capsule shell to give a filled hard gelatine capsule shell, wherein the gelatin capsule shell has an outer surface and an inner surface; and
(c) coating the outer surface of the filled hard gelatine capsule shell with the enteric coating solution or dispersion.

### Claim 2

A process for manufacturing an oral pharmaceutical preparation of a core formulation comprising a dry mix of an acid-unstable drug and an alkaline substance, wherein the acid-unstable drug is omeprazole, sodium omeprazole, potassium omeprazole, lansoprazole, or a pharmaceutical salt of lansoprazole, the process consisting essentially of:
(a) preparing the core formulation by dry mixing, without using an aqueous granulating solution, the acid-unstable drug with the alkaline substance;
(b) directly compressing the core granulation into a tablet;
(c) filling the tablet into the hard gelatine capsule shell having an outer surface and an inner surface; and
(d) coating the outer surface of the hard gelatine capsule shell with an enteric coating solution or dispersion.
